<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03619694</url>
  </required_header>
  <id_info>
    <org_study_id>MRS in brain tumors</org_study_id>
    <nct_id>NCT03619694</nct_id>
  </id_info>
  <brief_title>Role of MR Spectroscopy in Brain Tumors</brief_title>
  <official_title>Role of Magnetic Resonance Spectroscopy in Differentiating Brain Tumors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In order to come as close as possible to the correct diagnosis of CNS tumors, MRI is the
      long-standing accepted method of choice that can in some cases be supported by the use of CT
      to demonstrate calcification or bone destruction. In individual cases MRI spectroscopy can be
      helpful for the differentiation between neoplasms and inflammatory lesions or surveillance of
      tumor therapy, just as perfusion
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Proton magnetic resonance spectroscopy (H-MRS) may be helpful in suggesting tumor histology
      and tumor grade and may better define tumor extension and the ideal site for biopsy compared
      with conventional magnetic resonance (MR) imaging. A multifunctional approach with
      diffusion-weighted imaging, perfusion-weighted imaging, and permeability maps, along with
      H-MRS, may enhance the accuracy of the diagnosis and characterization of brain tumors and
      estimation of therapeutic response. Integration of advanced imaging techniques with
      conventional MR imaging and the clinical history help to improve the accuracy, sensitivity,
      and specificity in differentiating tumors and nonneoplastic lesions.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2017</start_date>
  <completion_date type="Anticipated">October 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of MRS findings with the pathology of the specimens</measure>
    <time_frame>Baseline</time_frame>
    <description>Analysis of the MRS metabolites peaks and integral and test if they can differentiate the grades of brain tumors</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Brain Neoplasms</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MRI Spectroscopy</intervention_name>
    <description>Patient with brain SOL underwent MRI Spectroscopy to be compared with later pathology</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with brain tumors diagnosed by conventional imaging
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients with space-occupying lesions

        Exclusion Criteria:

          -  Post operative cases

          -  Non-neoplastic nature
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Mohamed AbdelWahab, Msc</last_name>
    <phone>01148918822</phone>
    <phone_ext>+20</phone_ext>
    <email>dr.assiut@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assiut University</name>
      <address>
        <city>Assiut</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Peitgen N, Papanagiotou P. [Intra-axial brain tumors in adults : On the basis of the 2016 WHO classification]. Radiologe. 2017 Sep;57(9):707-714. doi: 10.1007/s00117-017-0271-6. Review. German.</citation>
    <PMID>28667395</PMID>
  </reference>
  <reference>
    <citation>Brindle KM, Izquierdo-Garc√≠a JL, Lewis DY, Mair RJ, Wright AJ. Brain Tumor Imaging. J Clin Oncol. 2017 Jul 20;35(21):2432-2438. doi: 10.1200/JCO.2017.72.7636. Epub 2017 Jun 22. Review.</citation>
    <PMID>28640699</PMID>
  </reference>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 3, 2018</study_first_submitted>
  <study_first_submitted_qc>August 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 8, 2018</study_first_posted>
  <last_update_submitted>August 3, 2018</last_update_submitted>
  <last_update_submitted_qc>August 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Mohamed Abdelwahab</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

